Cargando…

Validation of user-friendly models predicting extracapsular extension in prostate cancer patients

OBJECTIVE: There are many models to predict extracapsular extension (ECE) in patients with prostate cancer. We aimed to externally validate several models in a Japanese cohort. METHODS: We included patients treated with robotic-assisted radical prostatectomy for prostate cancer. The risk of ECE was...

Descripción completa

Detalles Bibliográficos
Autores principales:	Blas, Leandro, Shiota, Masaki, Nagakawa, Shohei, Tsukahara, Shigehiro, Matsumoto, Takashi, Lee, Ken, Monji, Keisuke, Kashiwagi, Eiji, Inokuchi, Junichi, Eto, Masatoshi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Second Military Medical University 2023
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9875152/ https://www.ncbi.nlm.nih.gov/pubmed/36721693 http://dx.doi.org/10.1016/j.ajur.2022.02.008

Ejemplares similares

Differential Impact of TGFB1 Variation by Metastatic Status in Androgen-Deprivation Therapy for Prostate Cancer
por: Shiota, Masaki, et al.
Publicado: (2021)

Psoas Muscle Volume Is a Predictive Marker of Fatigue and Anorexia in Prostate Cancer Patients Treated with Enzalutamide
por: Kashiwagi, Eiji, et al.
Publicado: (2022)

Anticancer Effect of Second-line Treatment for Castration-Resistant Prostate Cancer Following First-line Treatment with Androgen Receptor Pathway Inhibitors
por: Matsumoto, Takashi, et al.
Publicado: (2021)

Gene amplification of YB‐1 in castration‐resistant prostate cancer in association with aberrant androgen receptor expression
por: Shiota, Masaki, et al.
Publicado: (2020)

Relationship between body composition and hormone sensitivity for androgen deprivation therapy in patients with metastatic prostate cancer
por: Kashiwagi, Eiji, et al.
Publicado: (2020)

An oral first‐in‐class small molecule RSK inhibitor suppresses AR variants and tumor growth in prostate cancer
por: Ushijima, Miho, et al.
Publicado: (2022)

Prognostic significance of risk stratification in CHAARTED and LATITUDE studies among Japanese men with castration-resistant prostate cancer
por: Chikamatsu, Sotaro, et al.
Publicado: (2022)

Prognostic impact of dose reduction in androgen receptor pathway inhibitors for castration-resistant prostate cancer
por: Yamada, Shigetomo, et al.
Publicado: (2022)

Prognostic significance of diabetes mellitus and dyslipidemia in men receiving androgen-deprivation therapy for metastatic prostate cancer
por: Hirata, Yu, et al.
Publicado: (2019)

Role of Olaparib in the Management of Metastatic Castration-Resistant Prostate Cancer: A Japanese Clinician’s Perspective
por: Matsumoto, Takashi, et al.
Publicado: (2022)

Current Status and Future Perspective on the Management of Lymph Node-Positive Prostate Cancer after Radical Prostatectomy
por: Shiota, Masaki, et al.
Publicado: (2022)

Active Surveillance in Intermediate-Risk Prostate Cancer: A Review of the Current Data
por: Blas, Leandro, et al.
Publicado: (2022)

Cancer genomic profiling identified dihydropyrimidine dehydrogenase deficiency in bladder cancer promotes sensitivity to gemcitabine
por: Tsukahara, Shigehiro, et al.
Publicado: (2022)

The Role of Nuclear Receptors in Prostate Cancer
por: Shiota, Masaki, et al.
Publicado: (2019)

Neoadjuvant androgen-deprivation therapy with radical prostatectomy for prostate cancer in association with age and serum testosterone
por: Akitake, Naoko, et al.
Publicado: (2018)

Prognostic Impact of Genetic Polymorphism in Mineralocorticoid Receptor and Comorbidity With Hypertension in Androgen-Deprivation Therapy
por: Shiota, Masaki, et al.
Publicado: (2018)

Collateral resistance to taxanes in enzalutamide‐resistant prostate cancer through aberrant androgen receptor and its variants
por: Shiota, Masaki, et al.
Publicado: (2018)

Equol inhibits prostate cancer growth through degradation of androgen receptor by S‐phase kinase‐associated protein 2
por: Itsumi, Momoe, et al.
Publicado: (2016)

Doxycycline induces apoptosis via ER stress selectively to cells with a cancer stem cell-like properties: importance of stem cell plasticity
por: Matsumoto, Takashi, et al.
Publicado: (2017)

Extracellular vesicles expressing CEACAM proteins in the urine of bladder cancer patients
por: Igami, Ko, et al.
Publicado: (2022)

Profile of pembrolizumab in the treatment of patients with unresectable or metastatic urothelial carcinoma
por: Inokuchi, Junichi, et al.
Publicado: (2019)

Development of an Indian nomogram for predicting extracapsular extension in prostate cancer
por: Ravi, Chandran, et al.
Publicado: (2021)

Radiologic-pathologic correlation of prostatic cancer extracapsular extension (ECE)
por: Guerra, Adalgisa, et al.
Publicado: (2023)

Preoperative Factors Predictive of Posterolateral Extracapsular Extension After Radical Prostatectomy
por: Pak, Sahyun, et al.
Publicado: (2013)

Long‐term outcomes of androgen deprivation therapy in prostate cancer among Japanese men over 80 years old
por: Blas, Leandro, et al.
Publicado: (2021)

Side-specific, Microultrasound-based Nomogram for the Prediction of Extracapsular Extension in Prostate Cancer
por: Pedraza, Adriana M., et al.
Publicado: (2022)

Taxane Chemotherapy for Hormone-Naïve Prostate Cancer with Its Expanding Role as Breakthrough Strategy
por: Shiota, Masaki, et al.
Publicado: (2016)

Multi-parametric MRI of the prostate: Factors predicting extracapsular extension at the time of radical prostatectomy
por: Gaunay, Geoffrey S., et al.
Publicado: (2017)

Utility of quantitative contrast-enhanced ultrasound for the prediction of extracapsular extension in papillary thyroid carcinoma
por: Liu, Yi, et al.
Publicado: (2017)

Predictors of Extracapsular Extension in Patients With Squamous Cell Carcinoma of the Head and Neck and Outcome Analysis
por: Vengaloor Thomas, Toms, et al.
Publicado: (2021)

Early biomarkers of extracapsular extension of prostate cancer using MRI-derived semantic features
por: Guerra, Adalgisa, et al.
Publicado: (2022)

Preoperative Prediction and Identification of Extracapsular Extension in Head and Neck Cancer Patients: Progress and Potential
por: Duggar, William N, et al.
Publicado: (2023)

A user-friendly interface and extensions to the POISCR program package
por: Hofer, H
Publicado: (1986)

Extracapsular extension is not a significant prognostic indicator in non-squamous cancers of the major salivary glands
por: Cheraghlou, Shayan, et al.
Publicado: (2018)

Value of adding the apparent diffusion coefficient to capsular contact for the prediction of extracapsular extension in prostate cancer
por: da Silva Filho, Antonio Cordeiro, et al.
Publicado: (2020)

MRI-based radiomics models to assess prostate cancer, extracapsular extension and positive surgical margins
por: He, Dong, et al.
Publicado: (2021)

Correction: Early biomarkers of extracapsular extension of prostate cancer using MRI-derived semantic features
por: Guerra, Adalgisa, et al.
Publicado: (2023)

Prediction of extracapsular extension in prostate cancer using the Likert scale combined with clinical and pathological parameters
por: Wang, Jun-guang, et al.
Publicado: (2023)

External Validation of a Prognostic Model Predicting Metastatic Castration-Resistant Prostate Cancer Survival in Patients Receiving Post-Docetaxel Second-Line Chemotherapy
por: Blas, Leandro, et al.
Publicado: (2022)

Genetic variations predicting progression with docetaxel and novel androgen‐receptor pathway inhibitors
por: Shiota, Masaki, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_lflldqt3o6cibh4kdhcosim08q